Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
jRCTs041210114Completed
Open-label, single-arm trial of metronidazole in endometrioma. Primary endpoint: Recurrence rate of ovarian endometriotic cysts. Started Feb 2022; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on jRCTs041210114.